| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 1 31-39, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
ML Rodriguez-Puebla, AI Robles, DG Johnson, M LaCava and CJ Conti
The University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville 78957, USA.
Much of what is known about the mammalian cell cycle comes from studies using established cell lines in culture. In this study, cell cycle-regulatory events were analyzed in vivo after treatment of mouse epidermis with 12-O-tetradecanoylphorbol-13-acetate. A synchronized wave of basal keratinocyte proliferation occurred; over 80% of the cells were in S phase 15 h after treatment. c-myc protein expression was induced, and p57Kip2 protein levels dropped early after stimulation. Before S phase, cyclin D1 and cyclin-dependent kinase (CDK) 6 levels increased, and expression of cyclins E and A was induced. Rb was phosphorylated in late G1, and this correlates with the formation of cyclin D1/CDK4 and cyclin D1/CDK6 complexes. At the end of S phase, the p57Kip2 and p21Cip1 protein levels increased. These findings demonstrate that stimulation of basal epidermal cells by 12-O-tetradecanoylphorbol-13-acetate results in several classic cell cycle events and suggests that p57Kip2 plays a key role in regulating proliferation in the epidermis.
This article has been cited by other articles:
![]() |
E. Donet, P. Bosch, A. Sanchis, P. Bayo, A. Ramirez, J. L. Cascallana, A. Bravo, and P. Perez Transrepression Function of the Glucocorticoid Receptor Regulates Eyelid Development and Keratinocyte Proliferation but Is Not Sufficient to Prevent Skin Chronic Inflammation Mol. Endocrinol., April 1, 2008; 22(4): 799 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Macias, P. L. Miliani de Marval, A. Senderowicz, J. Cullen, and M. L. Rodriguez-Puebla Expression of CDK4 or CDK2 in Mouse Oral Cavity Is Retained in Adult Pituitary with Distinct Effects on Tumorigenesis Cancer Res., January 1, 2008; 68(1): 162 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Segrelles, J. Lu, B. Hammann, M. Santos, M. Moral, J. L. Cascallana, M. F. Lara, O. Rho, S. Carbajal, J. Traag, et al. Deregulated Activity of Akt in Epithelial Basal Cells Induces Spontaneous Tumors and Heightened Sensitivity to Skin Carcinogenesis Cancer Res., November 15, 2007; 67(22): 10879 - 10888. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Tiano, C. D. Loftin, J. Akunda, C. A. Lee, J. Spalding, A. Sessoms, D. B. Dunson, E. G. Rogan, S. G. Morham, R. C. Smart, et al. Deficiency of Either Cyclooxygenase (COX)-1 or COX-2 Alters Epidermal Differentiation and Reduces Mouse Skin Tumorigenesis Cancer Res., June 1, 2002; 62(12): 3395 - 3401. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Miliani de Marval, I. B. Gimenez-Conti, M. LaCava, L. A. Martinez, C. J. Conti, and M. L. Rodriguez-Puebla Transgenic Expression of Cyclin-Dependent Kinase 4 Results in Epidermal Hyperplasia, Hypertrophy, and Severe Dermal Fibrosis Am. J. Pathol., July 1, 2001; 159(1): 369 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Rodriguez-Puebla, M. LaCava, P. L. Miliani de Marval, J. L. Jorcano, E. R. Richie, and C. J. Conti Cyclin D2 Overexpression in Transgenic Mice Induces Thymic and Epidermal Hyperplasia whereas Cyclin D3 Expression Results Only in Epidermal Hyperplasia Am. J. Pathol., September 1, 2000; 157(3): 1039 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Reddig, N. E. Dreckschimdt, H. Ahrens, R. Simsiman, C.-P. Tseng, J. Zou, T. D. Oberley, and A. K. Verma Transgenic Mice Overexpressing Protein Kinase C{{delta}} in the Epidermis Are Resistant to Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-acetate Cancer Res., November 1, 1999; 59(22): 5710 - 5718. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhao and R. Agarwal Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention Carcinogenesis, November 1, 1999; 20(11): 2101 - 2108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Rodriguez-Puebla, M. LaCava, and C. J. Conti Cyclin D1 Overexpression in Mouse Epidermis Increases Cyclin-dependent Kinase Activity and Cell Proliferation in Vivo but Does Not Affect Skin Tumor Development Cell Growth Differ., July 1, 1999; 10(7): 467 - 472. [Abstract] [Full Text] |
||||
![]() |
M. Lahiri-Chatterjee, S. K. Katiyar, R. R. Mohan, and R. Agarwal A Flavonoid Antioxidant, Silymarin, Affords Exceptionally High Protection against Tumor Promotion in the SENCAR Mouse Skin Tumorigenesis Model Cancer Res., February 1, 1999; 59(3): 622 - 632. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |